Research Article
Intravenous Mistletoe Treatment in Integrative Cancer Care: A Qualitative Study Exploring the Procedures, Concepts, and Observations of Expert Doctors
Table 1
Sample characteristics: doctors using MT and integrative cancer care.
| | Number | Years | Median (range) |
| Doctors | 35 | | Men | 30 | | Women | 5 | | Age (years) | | 55 (40–84) | Specialty of doctor | | | Oncology, hematology | 8 | | Internal medicine, pulmonology, or gastroenterology | 17 | | General practitioner | 12 | | Pediatrician | 3 | | Gynecology | 1 | | Neurology | 1 | | Research doctor | 1 | | Work experience as a physician | | 26 (11–57) | Cancer patients treated with ME/year: median (range) | 270 (13–1,000) | | Using intravenous ME application | 29 | | Regularly | 3 | | Rarely | 6 | | Setting | | | Hospital or outpatient clinic | 21 | | Resident doctor | 14 | | Working in or collaborating with cancer centers | 35 | | Country of workplace | | | Germany | 22 | | Switzerland | 6 | | England, France, Sweden, Italy, Czech Republic, Egypt, Peru | 1 from each country | |
|
|
Some doctors had several specialties and are mentioned twice.
|